Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

TuHURA Biosciences, Inc. - Common Stock (NQ:HURA)

0.7151 -0.1003 (-12.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	625,133
Open	0.8256
Bid (Size)	0.7500 (2,800)
Ask (Size)	0.7900 (1,000)
Prev. Close	0.8154
Today's Range	0.7100 - 0.8387
52wk Range	0.7100 - 5.500
Shares Outstanding	1,746,408
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Keep an eye on the top gainers and losers in Tuesday's session. ↗

December 09, 2025

Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

What's going on in today's session ↗

December 09, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Performance

YTD	-82.6%	-82.6%
1 Month	-62.2%	-62.2%
3 Month	-71.4%	-71.4%
6 Month	-69.6%	-69.6%
1 Year	-82.8%	-82.8%

More News

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

December 09, 2025

Via Chartmill

TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

March 10, 2025

Via ACCESS Newswire

TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

February 19, 2025

Via ACCESS Newswire

TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.

December 12, 2024

Via ACCESSWIRE

TuHURA R&D Jumps 75% in Q2 ↗

August 14, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 13, 2025

Via Benzinga

Unusual volume stocks are being observed in Wednesday's session. ↗

August 13, 2025

Via Chartmill

Florida Rep. Laurel Lee Sold Up to $265K Worth of Alibaba Gr Hldgs Stock ↗

August 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 11, 2025

Via Benzinga

Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline ↗

June 23, 2025

Via Stocktwits

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 23, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

April 02, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 12, 2025

Via Benzinga

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

March 11, 2025

Via ACCESS Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders

December 20, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, ML, HURA, KANT on Behalf of Shareholders

December 18, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders

December 14, 2024

From Halper Sadeh LLC

Via GlobeNewswire

HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders

December 12, 2024

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 27, 2024

Via Benzinga

TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update

November 25, 2024

Via ACCESSWIRE

Frequently Asked Questions

Is TuHURA Biosciences, Inc. - Common Stock publicly traded?

Yes, TuHURA Biosciences, Inc. - Common Stock is publicly traded.

What exchange does TuHURA Biosciences, Inc. - Common Stock trade on?

TuHURA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for TuHURA Biosciences, Inc. - Common Stock?

The ticker symbol for TuHURA Biosciences, Inc. - Common Stock is HURA on the Nasdaq Stock Market

What is the current price of TuHURA Biosciences, Inc. - Common Stock?

The current price of TuHURA Biosciences, Inc. - Common Stock is 0.7151

When was TuHURA Biosciences, Inc. - Common Stock last traded?

The last trade of TuHURA Biosciences, Inc. - Common Stock was at 12/23/25 04:00 PM ET

What is the market capitalization of TuHURA Biosciences, Inc. - Common Stock?

The market capitalization of TuHURA Biosciences, Inc. - Common Stock is 1.25M

How many shares of TuHURA Biosciences, Inc. - Common Stock are outstanding?

TuHURA Biosciences, Inc. - Common Stock has 1M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.